BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cheng AY, Kong AP, Wong VW, So WY, Chan HL, Ho CS, Lam CW, Tam JS, Chow CC, Cockram CS. Chronic hepatitis B viral infection independently predicts renal outcome in type 2 diabetic patients. Diabetologia. 2006;49:1777-1784. [PMID: 16736132 DOI: 10.1007/s00125-006-0294-4] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 Choudhary NS, Saraf N, Kumar N, Rai R, Saigal S, Gautam D, Lipi L, Rastogi A, Goja S, Bhangui P. Nonalcoholic fatty liver is not associated with incident chronic kidney disease: a large histology-based comparison with healthy individuals. Eur J Gastroenterol Hepatol. 2016;28:441-443. [PMID: 26636408 DOI: 10.1097/meg.0000000000000531] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
2 Cai J, Fan X, Mou L, Gao B, Liu X, Li J, Liu L, Wang H, Guo Z, Liu X, Li H, Li X, Li X. Association of reduced renal function with hepatitis B virus infection and elevated alanine aminotransferase. Clin J Am Soc Nephrol 2012;7:1561-6. [PMID: 22859746 DOI: 10.2215/CJN.07410711] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
3 Chan JC, So W, Ma RC, Tong PC, Wong R, Yang X. The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry. Curr Cardiovasc Risk Rep 2011;5:230-9. [PMID: 21654912 DOI: 10.1007/s12170-011-0172-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
4 Kong APS, Xu G, Brown N, So W, Ma RCW, Chan JCN. Diabetes and its comorbidities—where East meets West. Nat Rev Endocrinol 2013;9:537-47. [DOI: 10.1038/nrendo.2013.102] [Cited by in Crossref: 91] [Cited by in F6Publishing: 81] [Article Influence: 11.4] [Reference Citation Analysis]
5 Wang CS, Chang TT, Yao WJ, Wang ST, Chou P. The impact of smoking on incident type 2 diabetes in a cohort with hepatitis B but not hepatitis C infection. J Viral Hepat. 2017;24:1114-1120. [PMID: 20819148 DOI: 10.1111/j.1365-2893.2010.01337.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
6 Chan JC, Lau ES, Luk AO, Cheung KK, Kong AP, Yu LW, Choi K, Chow FC, Ozaki R, Brown N, Yang X, Bennett PH, Ma RC, So W. Premature Mortality and Comorbidities in Young-onset Diabetes: A 7-Year Prospective Analysis. The American Journal of Medicine 2014;127:616-24. [DOI: 10.1016/j.amjmed.2014.03.018] [Cited by in Crossref: 67] [Cited by in F6Publishing: 59] [Article Influence: 9.6] [Reference Citation Analysis]
7 Targher G, Kendrick J, Smits G, Chonchol M. Relationship between serum gamma-glutamyltransferase and chronic kidney disease in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Nutr Metab Cardiovasc Dis. 2010;20:583-590. [PMID: 19699624 DOI: 10.1016/j.numecd.2009.05.012] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.3] [Reference Citation Analysis]
8 Jenks SJ, Conway BR, Hor TJ, Williamson RM, Mclachlan S, Robertson C, Morling JR, Strachan MWJ, Price JF. Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes. Diabet Med 2014;31:1039-46. [DOI: 10.1111/dme.12456] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
9 Fabrizi F, Cerutti R, Ridruejo E. Hepatitis B virus infection as a risk factor for chronic kidney disease. Expert Rev Clin Pharmacol 2019;12:867-74. [PMID: 31456441 DOI: 10.1080/17512433.2019.1657828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kong XL, Ma XJ, Su H, Xu DM. Relationship between occult hepatitis B virus infection and chronic kidney disease in a Chinese population-based cohort. Chronic Dis Transl Med 2016;2:55-60. [PMID: 29063026 DOI: 10.1016/j.cdtm.2016.07.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Yu DY. Relevance of reactive oxygen species in liver disease observed in transgenic mice expressing the hepatitis B virus X protein. Lab Anim Res 2020;36:6. [PMID: 32206612 DOI: 10.1186/s42826-020-00037-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Targher G, Chonchol M, Bertolini L, Rodella S, Zenari L, Lippi G, Franchini M, Zoppini G, Muggeo M. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008;19:1564-1570. [PMID: 18385424 DOI: 10.1681/asn.2007101155] [Cited by in Crossref: 122] [Cited by in F6Publishing: 51] [Article Influence: 9.4] [Reference Citation Analysis]
13 Khoo CM, Deerochanawong C, Chan SP, Matawaran B, Sheu WH, Chan J, Mithal A, Luk A, Suastika K, Yoon KH, Ji L, Man NH, Pollock C. Use of sodium-glucose co-transporter-2 inhibitors in Asian patients with type 2 diabetes and kidney disease: An Asian perspective and expert recommendations. Diabetes Obes Metab 2021;23:299-317. [PMID: 33155749 DOI: 10.1111/dom.14251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Luk A, Chan JC. Diabetic nephropathy--what are the unmet needs? Diabetes Res Clin Pract 2008;82 Suppl 1:S15-20. [PMID: 18952313 DOI: 10.1016/j.diabres.2008.09.033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
15 Shin HJ, Park YH, Kim SU, Moon HB, Park DS, Han YH, Lee CH, Lee DS, Song IS, Lee DH. Hepatitis B virus X protein regulates hepatic glucose homeostasis via activation of inducible nitric oxide synthase. J Biol Chem. 2011;286:29872-29881. [PMID: 21690090 DOI: 10.1074/jbc.m111.259978] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
16 Targher G, Bosworth C, Kendrick J, Smits G, Lippi G, Chonchol M. Relationship of serum bilirubin concentrations to kidney function and albuminuria in the United States adult population. Findings from the National Health and Nutrition Examination Survey 2001-2006. Clin Chem Lab Med. 2009;47:1055-1062. [PMID: 19634983 DOI: 10.1515/cclm.2009.244] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
17 Zou QL, Wei GN, Chen JX, Ye Q, Shan PF. Hepatitis B virus-associated nephropathy in a patient with diabetes mellitus. J Diabetes Investig 2014;5:87-9. [PMID: 24843742 DOI: 10.1111/jdi.12125] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Ma RC, Chan JC. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann N Y Acad Sci. 2013;1281:64-91. [PMID: 23551121 DOI: 10.1111/nyas.12098] [Cited by in Crossref: 401] [Cited by in F6Publishing: 368] [Article Influence: 50.1] [Reference Citation Analysis]
19 Cockram CS, Wong BC. Diabetes and Infections. In: Holt RIG, Cockram CS, Flyvbjerg A, Goldstein BJ, editors. Textbook of Diabetes. Chichester: John Wiley & Sons, Ltd; 2017. pp. 799-818. [DOI: 10.1002/9781118924853.ch55] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
20 Chan JC, Cho NH, Tajima N, Shaw J. Diabetes in the Western Pacific Region--past, present and future. Diabetes Res Clin Pract 2014;103:244-55. [PMID: 24418400 DOI: 10.1016/j.diabres.2013.11.012] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 7.1] [Reference Citation Analysis]
21 Mantovani A, Zusi C, Dalbeni A, Grani G, Buzzetti E. Risk of Kidney Dysfunction IN Nafld. CPD 2020;26:1045-61. [DOI: 10.2174/1381612825666191026113119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
22 Chen YC, Li CY, Tsai SJ, Chen YC. Nationwide cohort study suggests that nucleos(t)ide analogue therapy decreases dialysis risk in Taiwanese chronic kidney disease patients acquiring hepatitis B virus infection. World J Gastroenterol 2018; 24(8): 917-928 [PMID: 29491685 DOI: 10.3748/wjg.v24.i8.917] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
23 Fabrizi F, Donato FM, Messa P.  Association between hepatitis B virus and chronic kidney disease: a systematic review and meta-analysis. Ann Hepatol 2017;16:21-47. [PMID: 28051791 DOI: 10.5604/16652681.1226813] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
24 Chen YC, Su YC, Li CY, Wu CP, Lee MS. A nationwide cohort study suggests chronic hepatitis B virus infection increases the risk of end-stage renal disease among patients in Taiwan. Kidney Int. 2015;87:1030-1038. [PMID: 25426815 DOI: 10.1038/ki.2014.363] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
25 李磊, 丁惠国. 代谢综合征对慢性病毒性肝炎临床转归的影响及其机制. 世界华人消化杂志 2010; 18(19): 2029-2032 [DOI: 10.11569/wcjd.v18.i19.2029] [Reference Citation Analysis]
26 Fabrizi F, Cerutti R, Donato FM, Messa P. HBV infection is a risk factor for chronic kidney disease: Systematic review and meta-analysis. Rev Clin Esp (Barc) 2021:S2254-8874(21)00112-0. [PMID: 34183297 DOI: 10.1016/j.rceng.2019.10.014] [Reference Citation Analysis]
27 Targher G, Bertolini L, Rodella S, Zoppini G, Lippi G, Day C, Muggeo M. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51:444-450. [PMID: 18058083 DOI: 10.1007/s00125-007-0897-4] [Cited by in Crossref: 198] [Cited by in F6Publishing: 174] [Article Influence: 14.1] [Reference Citation Analysis]
28 Targher G, Byrne CD. Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease. Nat Rev Nephrol. 2017;13:297-310. [PMID: 28218263 DOI: 10.1038/nrneph.2017.16] [Cited by in Crossref: 115] [Cited by in F6Publishing: 109] [Article Influence: 28.8] [Reference Citation Analysis]
29 Chan JCN, Chow EYK, Luk AO. Diabetes in China and the Western Pacific Region. In: Dagogo-jack S, editor. Diabetes Mellitus in Developing Countries and Underserved Communities. Cham: Springer International Publishing; 2017. pp. 63-83. [DOI: 10.1007/978-3-319-41559-8_5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
30 Kim SE, Jang ES, Ki M, Gwak GY, Kim KA, Kim GA, Kim DY, Kim DJ, Kim MW, Kim YS, Kim YS, Kim IH, Kim CW, Kim HD, Kim HJ, Park NH, Baik SK, Suh JI, Song BC, Song IH, Yeon JE, Lee BS, Lee YJ, Jung YK, Chung WJ, Cho SB, Cho EY, Cho HC, Cheon GJ, Chae HB, Choi D, Choi SK, Choi HY, Tak WY, Heo J, Jeong SH. Chronic Hepatitis B Infection Is Significantly Associated with Chronic Kidney Disease: a Population-based, Matched Case-control Study. J Korean Med Sci 2018;33:e264. [PMID: 30310365 DOI: 10.3346/jkms.2018.33.e264] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
31 Targher G, Bertolini L, Rodella S, Lippi G, Zoppini G, Chonchol M. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol 2010;5:2166-71. [PMID: 20724519 DOI: 10.2215/CJN.05050610] [Cited by in Crossref: 128] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
32 Yasin M, Zafar S, Rahman H, Khan TA, Nazir S, Shah S, Dawood M, Ahmad S, Basit A, Khan SN, Saleha S. Baseline characteristics of infected foot ulcers in patients with diabetes at a tertiary care hospital in Pakistan. J Wound Care. 2018;27:S26-S32. [PMID: 30307815 DOI: 10.12968/jowc.2018.27.sup10.s26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Qin S, Wang S, Wang X, Wang J. Liver stiffness assessed by transient elastography as a potential indicator of chronic kidney disease in patients with nonalcoholic fatty liver disease. J Clin Lab Anal. 2019;33:e22657. [PMID: 30239032 DOI: 10.1002/jcla.22657] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Wong GL, Chan HL, Tse YK, Yip TC, Lam KL, Lui GC, Szeto CC, Wong VW. Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment. Aliment Pharmacol Ther. 2018;48:984-992. [PMID: 30125952 DOI: 10.1111/apt.14945] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
35 Targher G, Chonchol M, Zoppini G, Abaterusso C, Bonora E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link? Journal of Hepatology 2011;54:1020-9. [DOI: 10.1016/j.jhep.2010.11.007] [Cited by in Crossref: 101] [Cited by in F6Publishing: 99] [Article Influence: 10.1] [Reference Citation Analysis]